Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.
Clinical trial NCT07377175 · RECRUITING
Trial details
- NCT number
- NCT07377175
- Sponsor
- China National Biotec Group Company Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2026-02-13
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.